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Abstract
Background: Analyzing apoptosis has been an integral component of many biological studies.
However, currently available methods for quantifying apoptosis have various limitations including
multiple, sometimes cell-damaging steps, the inability to quantify live, necrotic and apoptotic cells
at the same time, and non-specific detection (i.e. "false positive"). To overcome the shortcomings
of current methods that quantify apoptosis in vitro and to take advantage of the 96-well plate format,
we present here a modified ethidium bromide and acridine orange (EB/AO) staining assay, which
may be performed entirely in a 96-well plate. Our method combines the advantages of the 96-well
format and the conventional EB/AO method for apoptotic quantification.
Results: We compared our method and the conventional EB/AO method for quantifying apoptosis
of suspension cells (Jurkat) and adherent cells (A375) under normal growth and apoptosis-inducing
conditions. We found that our new EB/AO method achieved quantification results comparable to
those produced using the conventional EB/AO method for both suspension and adherent cells.
Conclusion: By eliminating the detaching and washing steps, our method drastically reduces the
time needed to perform the test, minimizes damage to adherent cells, and decreases the possibility
of losing floating cells. Overall, our method is an improvement over the currently available
techniques especially for adherent cells.
Background
Apoptosis, a type of programmed cell death, is an active
process. It is a normal component of the development
and health of multicellular organisms. The study of apop-
tosis is an important field of biological inquiry since a
deficiency or an excess of apoptosis is one of the causes for
cancers, autoimmune disorders, diabetes, Alzheimer's,
organ and bone marrow transplant rejection, and many
other diseases. Accordingly, a quick and easy assay for
quantification of apoptosis would be very useful for many
biological researchers.
Currently, methods available to help detect apoptosis in
vitro  include several morphological staining methods
(such as ethidium bromide and acridine orange (EB/AO)
[1,2], DAPI (4; 6-diamidino-2phenylidole) [2], Hoechst
staining [2], and etc), Annexin V staining [3-6], DNA lad-
der [7,8], TUNEL (Terminal deoxynucleotidyl transferase
mediated dUTP Nick End Labeling) [9-11], Caspase-3/7
activity [12-16], and ssDNA staining [17-22]. However,
these methods have at least one of the following
limitations:
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1) Involvement of multiple steps
All current staining methods, Annexin V, and DNA ladder-
ing assays require detaching, washing and transferring the
cells. These procedures might damage the cell membranes
and change the cell population distribution of live, apop-
totic and/or necrotic cells. Procedures with multiple steps
also require more time to perform the assay, and more
materials allowing for loss of the cells through the
procedures.
2) Lack of the ability to quantify live, apoptotic and 
necrotic cells at the same time
DAPI staining, caspase-3/7 activity, DNA laddering, and
ssDNA staining methods only detect increase of apoptotic
signals, and can not easily quantify percentage of live,
apoptotic, and necrotic cells.
3) Non-specific detection
The TUNEL assay is widely used for detecting apoptotic
cells. However, it has been shown to provide false positive
signals in some necrotic cells [18,21,22].
Despite the many characteristics of apoptotic cells ana-
lyzed by current methods, chromatin condensation and
nuclear fragmentation remain the hallmarks of apoptotic
cells [1,23-25]. It has been suggested that as a rule, classi-
fication of cell death in a given model should always
include morphological examination coupled with at least
one other assay [26]. Fluorescence light microscopy with
differential uptake of fluorescent DNA binding dyes (such
as EB/AO staining) is a method of choice for its simplicity,
rapidity, and accuracy. In such an assay, apoptotic index
and cell membrane integrity can be assessed simultane-
ously and there is no cell fixation step, thus avoiding a
number of potential artifacts [26]. Acridine orange (AO)
permeates all cells and makes the nuclei appear green.
Ethidium bromide (EB) is only taken up by cells when
cytoplasmic membrane integrity is lost, and stains the
nucleus red. EB also dominates over AO. Thus live cells
have a normal green nucleus; early apoptotic cells have
bright green nucleus with condensed or fragmented chro-
matin; late apoptotic cells display condensed and frag-
mented orange chromatin; cells that have died from direct
necrosis have a structurally normal orange nucleus [26].
A 96-well plate format is ideal for examining multiple cell
types and performing multiple assays while using very
small amounts of materials. It is also a suitable format for
high throughput drug screening. To overcome the short-
comings of current methods that quantify apoptosis in
vitro, and to take advantage of the 96-well plate format, we
present here an improved EB/AO staining assay per-
formed entirely in a 96-well plate.
Results and Discussion
We modified the conventional EB/AO method by centri-
fuging the cells in a 96-well plate to bring down all the
cells, including floaters, to the bottom of the plate. Using
this method, we obtained quantification of live, necrotic,
and apoptotic cells for both suspension cells (Jurkat, Fig-
ure 1), and adherent cells (A375, Figure 2), under normal
growth and apoptosis-inducing conditions that was com-
parable to the conventional EB/AO method.
Figure 1 compares the results from our method and the
conventional EB/AO methods for both control and
treated Jurkat cells. Figure 1A exemplifies cell morphology
obtained using both methods. We note that the definition
is sharper by eye through the microscope than in the pho-
tos. In addition, the pictures obtained using the conven-
tional method, which uses microscope slides, were
sharper than those produced using the 96-well based
method. This might be due to the relatively poor optical
quality of the plastic bottom of 96-well plates. However,
this did not encumber the quantification of live, apop-
totic, and necrotic cells using the 96-well based method.
Further, if high optical clarity is desirable, one may use
glass-bottom 96-well plates to eliminate this possible lim-
itation, or use a microscope with Hoffman modulation
contrast to increase the optical quality of the plastic [27].
Determining the live, apoptotic and necrotic cells was
comparable between these two methods for Jurkat cells:
A) live cells have normal nuclei staining which present
green chromatin with organized structures; B) apoptotic
cells contain condensed or fragmented chromatin (green
or orange); C) necrotic cells have similar normal nuclei
staining as live cells except the chromatin is orange
instead of green.
Overall, quantification of live, necrotic, and apoptotic
control and treated Jurkat cells was quite comparable
using both methods (Figure 1B and 1C). The chi-square
tests showed that the cell counts were independent of the
method used for each treatment condition (For Jurkat
Control: Conventional vs. Modified, d.f. = 2, chi-square =
0.34, p > 0.8; For Jurkat Treated: Conventional vs. Modi-
fied, d.f. = 2, chi-square = 0.0015, p > 0.995). The largest
differences in cell counts between the methods were only
a 2% lower live cell count and a 2% higher apoptotic cell
count for the treated condition using the conventional
method (not statistically significant, Figure 1C). However,
these small variations would be within the standard devi-
ations of these assays. Thus, for suspension cells, the mod-
ified method was quite similar to the conventional
method in terms of quantification and detection of the
live, apoptotic, and necrotic cells.BMC Biotechnology 2005, 5:12 http://www.biomedcentral.com/1472-6750/5/12
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Comparison of a 96-well-based and the conventional EB/AO method for Jurkat suspension cells Figure 1
Comparison of a 96-well-based and the conventional EB/AO method for Jurkat suspension cells. Jurkat cells were 
treated with 6 µM camptothecin for induction of apoptosis. (A) -Images of the cells. Yellow arrows next to "L" point to live 
cells; white arrows next to "A" indicate apoptotic cells; and red arrows next to "N" indicate necrotic cells. (B) Quantification of 
untreated live, necrotic, and apoptotic cells. (C) Quantification of live, necrotic, and apoptotic cells treated with camptothecin. 
p-values from chi-square tests were marked on the bottom of each graph.BMC Biotechnology 2005, 5:12 http://www.biomedcentral.com/1472-6750/5/12
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Figure 2 shows the comparison between the modified and
conventional methods of staining for A375 adherent cells.
Figure 2A presents the morphology of A375 cells from dif-
ferent conditions using the conventional and our 96-well
based method. Our method illustrated the morphology of
live adherent cells attached to the plate in the control well,
and it showed rounded up, detached cells in the treated
well. This allowed us to observe more features for distin-
guishing live cells from apoptotic cells (Figure 2A). In con-
trast, all the cells stained from the conventional method
were rounded up since it requires one to detach the cells.
Thus, the modified method allows better morphological
assessment of apoptotic condition when compared to the
conventional staining technique.
As for Jurkat cells, the quantification of live, necrotic, and
apoptotic cell populations in both control and treated
A375 cells was quite comparable using both methods
(Figure 2B and 2C). The chi-square tests showed that the
cell counts were again statistically independent of the
staining method used for both treatment conditions (For
A375 Control: Conventional vs. Modified, d.f. = 2, chi-
square = 0.31, p > 0.8; For A375 Treated: Conventional vs.
Modified, d.f. = 2, chi-square = 0.86, p > 0.6). In this case,
the largest differences in quantification obtained using
these two methods were only 3% necrotic and apoptotic
cell counts for treated A375 cells (not statistically signifi-
cant, Figure 2C). Thus, in accordance with the suspension
cell results, the two staining methods were quite compara-
ble for adherent cells. Further, we also found similar
results with A375 cells treated with other apoptotic trig-
gers (data not shown).
We note that there was a lot more debris in the adherent
cell samples produced using the conventional method.
This suggests that the conventional method, with multiple
step preparation of adherent cells, could cause some cell
damage and break apart some highly fragile cells such as
late apoptotic or necrotic cells. This undesired artifact
might change the distribution of live, apoptotic, and
necrotic cells in the cell population under some
conditions.
These results suggest that our method is especially well
suited for analyzing adherent cells, since it provides fur-
ther characteristics to differentiate live cells from apop-
totic cells. Additionally, it is much easier to collect all the
cells, including floaters, than using the conventional
method. Furthermore, by eliminating the detaching and
washing steps, this method drastically reduces the time
needed to perform the test, decreases the possibility of los-
ing floating cells as in the conventional method, mini-
mizes damage to adherent cells, and may allow more
accurate quantification of apoptotic status under certain
conditions.
Table 1 summarizes the advantages and disadvantages
from various apoptotic detection methods including our
96-well-based EB/AO assay. Our method is the only one
with the advantages of having one-step, high specificity,
quantification of all three types of cells at the same time,
and available in a 96-well format.
Conclusion
We present here an improved EB/AO staining method by
substituting the detaching and washing steps with a sim-
pler centrifugation step with 96-well plates. This modified
method combines the advantage of the 96-well format
and the conventional EB/AO staining method for apop-
totic quantification. Our new technique is easy to per-
form, time efficient, and especially suitable for adherent
cells. In addition, inverted fluorescence microscopes and
96-well plate holders for centrifuges are readily available
in most research departments. Our new method only
requires small amounts of inexpensive EB and AO for
each experiment.
Table 1: Comparison of the advantages of various apoptotic detection methods.
ASSAY ONE-STEP QUANTIFICATION 
OF LIVE, NECROTIC 
AND APOPTOTIC 
CELLS
SPECIFICITY 96-WELL FORMAT
O u r  9 6 - w e l l - b a s e d  E B / A O ++++
Caspase 3/7 Activity + - + +
Conventional EB/AO - + + -
Annexin V/PI - + + -
ssDNA - - + +
DNA Laddering - - + -
T U N E L ---+
DAPI stain - - + -BMC Biotechnology 2005, 5:12 http://www.biomedcentral.com/1472-6750/5/12
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Comparison of a 96-well-based and the conventional EB/AO method for A375 adherent cells Figure 2
Comparison of a 96-well-based and the conventional EB/AO method for A375 adherent cells. A375 cells were 
treated with 6 µM camptothecin for induction of apoptosis. Symbols and labels are used in the same way as in Figure 1.BMC Biotechnology 2005, 5:12 http://www.biomedcentral.com/1472-6750/5/12
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Since this method is straightforward to perform with only
one step of gentle centrifugation using 96-well plates, it
can also be easily combined with other 96-well-plate-
based assays within one experiment, such as cell viability
assay (MTS), cell death assay (LDH), or certain caspase
activity assays. Therefore, multiple endpoints of cell death
and apoptosis can be measured in a single experiment
with very small amounts of cells. This could be very valu-
able for the cells difficult to grow in large amounts (e.g.,
the short term cultures of patient or animal samples).
In summary, our apoptotic quantification method repre-
sents an improvement over the currently available
techniques especially for adherent cells. It is highly spe-
cific, simple, time efficient, and available in a 96-well for-
mat. Further, it can quantify live, apoptotic and necrotic
cells at the same time.
Methods
Cell lines and normal culture conditions
Both A375 (a human melanoma cell line) and Jurkat (a
human leukemia T cell line) were obtained from ATCC
(American Type Culture Collection, Manassas, VA, USA).
Cells were maintained in RPMI Medium 1640 (Invitro-
gen, Grand Island, New York, USA) with 10% fetal bovine
serum (Gemini Bio-Products, Inc. CA, USA) and grown in
an incubator at 37°C with 5% CO2. All tissue culture
plates and other plastic wares were from Costar (Corning,
New York, USA).
Reagents
Camptothecin was purchased from Biovision (Mountain
View, CA, USA). Acridine orange (AO), ethidium bromide
(EB), and ethylenediamine-tetraacetic acid (EDTA) were
purchased from Sigma (St. Louis, MO, USA).
The dye mix for the EB/AO staining was 100 µg/ml acrid-
ine orange and 100 µg/ml ethidium bromide in PBS [2].
Induction of apoptosis in Jurkat cells with camptothecin 
treatment
Four ml of 5 × 105 cells/well were seeded in a 6-well plate
the night before the treatment. Cells were treated with
camptothecin at a final concentration of 6 µM for 4 hr in
the 37°C incubator before the cells were subjected to EB/
AO staining. Then, 1 ml of cell suspension was used for
conventional EB/AO staining, and 100 µl of cell suspen-
sion was transferred to a 96-well plate for modified EB/
AO staining.
Induction of apoptosis in A375 cells with camptothecin 
treatment
For the conventional EB/AO method, 2.5 × 105 cells/well
were seeded in a 6-well plate the night before the treat-
ment. For our modified EB/AO method, 1.6 × 104 cells/
well were seeded in a 96-well plate. Cells were treated with
camptothecin at a final concentration of 6 µM for 48 hr in
the incubator before the cells were subjected to EB/AO
staining procedure.
Conventional EB/AO staining
Procedures were followed as described previously in Cur-
rent Protocols of Immunology [1]. Briefly, cells were har-
vested as the following: 1) For suspension cells, 1 ml of
Jurkat cell suspensions was transferred to a 15 ml tube. 2)
For adherent cells, supernatant (medium and floating
A375 cells) were transferred to 15 ml tubes. The rest of the
adherent cells were detached with PBS-EDTA, Dulbecco's
phosphate buffered saline (Invitrogen, Grand Island, New
York, USA) containing 1 mM EDTA. The supernatant and
the detached cells from the same sample were pooled
together in the 15 ml tubes.
Both Jurkat and A375 cells were pelleted by centrifuged at
1,000 RPM (129 g) for 5 minutes using a Beckman Model
TJ-6 centrifuge, and washed with 1 ml of cold PBS once.
Cell pellets were then re-suspended in 25 µl cold PBS and
2 µl EB/AO dye mix was added. Stained cell suspension
(10 µl) were placed on a clean microscope slide and cov-
ered with a coverslip. Cells were viewed and counted
using a Nikon eclipse TS100 inverted microscope at 400×
magnification with excitation filter 480/30 nm; dichro-
matic mirror cut-on 505 nm LP; and barrier filter 535/40
nm (Melville, NY, USA). Pictures were taken with a Nikon
COLPIX digital camera. Tests were done in triplicate,
counting a minimum of 100 total cells each.
96-well-based EB/AO staining
For both suspension and adherent cells, 96-well plates
were centrifuged at 1,000 RPM (129 g) for 5 minutes
using a Beckman Model TJ-6 centrifuge with inserts for 96-
well plates. EB/AO dye mix (8 µl) was added to each well,
and cells were viewed under the same microscope as
above. Tests were done in triplicate, counting a minimum
of 100 total cells each.
Statistical analysis
To test the hypothesis that frequencies of observed live,
necrotic, and apoptotic cells were independent of the
staining method used, we employed chi-square tests for
independence in contingency tables using Microsoft
Excel. For each contingency table, triplicate counts of live,
necrotic, and apoptotic cells for both the traditional and
modified staining methods were averaged.
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